Drugging the gut microbiome - PubMed (original) (raw)

• PMID: 25748907
• DOI: 10.1038/nbt.3161

Drugging the gut microbiome

Ken Garber. Nat Biotechnol. 2015 Mar.

Erratum in

• Erratum: Drugging the gut microbiome.
  Garber K. Garber K. Nat Biotechnol. 2017 May 9;35(5):481. doi: 10.1038/nbt0517-481b. Nat Biotechnol. 2017. PMID: 28486466 No abstract available.

Abstract

Using conventional drug discovery and novel synthetic biology approaches, some investigators and companies are mining our resident microbes and their metabolites for targets in small-molecule drug programs. Ken Garber reports.

PubMed Disclaimer

Similar articles

• Targeting of microbe-derived metabolites to improve human health: The next frontier for drug discovery.
  Brown JM, Hazen SL. Brown JM, et al. J Biol Chem. 2017 May 26;292(21):8560-8568. doi: 10.1074/jbc.R116.765388. Epub 2017 Apr 7. J Biol Chem. 2017. PMID: 28389555 Free PMC article. Review.
• The Gut Microbiome, Its Metabolome, and Their Relationship to Health and Disease.
  Wu GD. Wu GD. Nestle Nutr Inst Workshop Ser. 2016;84:103-10. doi: 10.1159/000436993. Epub 2016 Jan 14. Nestle Nutr Inst Workshop Ser. 2016. PMID: 26764479
• Influence of early life exposure, host genetics and diet on the mouse gut microbiome and metabolome.
  Snijders AM, Langley SA, Kim YM, Brislawn CJ, Noecker C, Zink EM, Fansler SJ, Casey CP, Miller DR, Huang Y, Karpen GH, Celniker SE, Brown JB, Borenstein E, Jansson JK, Metz TO, Mao JH. Snijders AM, et al. Nat Microbiol. 2016 Nov 28;2:16221. doi: 10.1038/nmicrobiol.2016.221. Nat Microbiol. 2016. PMID: 27892936
• Obesity and Asthma: Microbiome-Metabolome Interactions.
  Shore SA, Cho Y. Shore SA, et al. Am J Respir Cell Mol Biol. 2016 May;54(5):609-17. doi: 10.1165/rcmb.2016-0052PS. Am J Respir Cell Mol Biol. 2016. PMID: 26949916 Free PMC article. Review.
• The gut microbiome, diet, and links to cardiometabolic and chronic disorders.
  Aron-Wisnewsky J, Clément K. Aron-Wisnewsky J, et al. Nat Rev Nephrol. 2016 Mar;12(3):169-81. doi: 10.1038/nrneph.2015.191. Epub 2015 Nov 30. Nat Rev Nephrol. 2016. PMID: 26616538 Review.

Cited by

• The gut microbiota in thrombosis.
  Khuu MP, Paeslack N, Dremova O, Benakis C, Kiouptsi K, Reinhardt C. Khuu MP, et al. Nat Rev Cardiol. 2024 Sep 17. doi: 10.1038/s41569-024-01070-6. Online ahead of print. Nat Rev Cardiol. 2024. PMID: 39289543 Review.
• Microbiota-related metabolites fueling the understanding of ischemic heart disease.
  Fan Y, Ying J, Ma H, Cui H. Fan Y, et al. Imeta. 2023 Feb 26;2(2):e94. doi: 10.1002/imt2.94. eCollection 2023 May. Imeta. 2023. PMID: 38868424 Free PMC article.
• The Emerging Role of the Gut Microbiome in Cardiovascular Disease: Current Knowledge and Perspectives.
  Papadopoulos PD, Tsigalou C, Valsamaki PN, Konstantinidis TG, Voidarou C, Bezirtzoglou E. Papadopoulos PD, et al. Biomedicines. 2022 Apr 20;10(5):948. doi: 10.3390/biomedicines10050948. Biomedicines. 2022. PMID: 35625685 Free PMC article. Review.
• Pharmacogenomics of NSAID-Induced Upper Gastrointestinal Toxicity.
  McEvoy L, Carr DF, Pirmohamed M. McEvoy L, et al. Front Pharmacol. 2021 Jun 21;12:684162. doi: 10.3389/fphar.2021.684162. eCollection 2021. Front Pharmacol. 2021. PMID: 34234675 Free PMC article. Review.
• Gut microbiota and cardiovascular disease: opportunities and challenges.
  Kazemian N, Mahmoudi M, Halperin F, Wu JC, Pakpour S. Kazemian N, et al. Microbiome. 2020 Mar 14;8(1):36. doi: 10.1186/s40168-020-00821-0. Microbiome. 2020. PMID: 32169105 Free PMC article. Review.

References

1. 1. Nat Med. 2014 Feb;20(2):159-66 - PubMed
2. 1. Cell. 2014 Sep 11;158(6):1402-14 - PubMed
3. 1. N Engl J Med. 2013 Jan 31;368(5):407-15 - PubMed
4. 1. Nature. 2013 Jul 4;499(7456):97-101 - PubMed
5. 1. Cell. 2013 Dec 19;155(7):1451-63 - PubMed

MeSH terms

LinkOut - more resources

• Full Text Sources

  • Nature Publishing Group

• Other Literature Sources

  • The Lens - Patent Citations Database